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CT findings in three cases with solitary fibrous tumors (SFTs) confirmed by histopathology and
immunohistochemistry were reviewed retrospectively, and compared with pathological results. The three tumors
were large, well-defined, and smooth contour masses and SFT consisted of solid components of two different
densities. On enhanced CT scans, tumors were strongly enhancing, the multiple vascular shadows were seen
within the tumor in the arterial phase. There is progressive enhancement from the arterial to the venous phase,
and the tumor capsule can be observed. Histologically, the tumors are composed of spindle cells within a background
of collagen stroma, and showed a wide range of growth patterns, alternating hypercellular (tumor cell-rich) and
hypocellular (collagen-rich) areas. The diagnosis is confirmed by characteristic positive immunohistochemical
staining for CD34.
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Solitary fibrous tumors (SFTs) are rare spindle-shaped
cell tumors originated from dendritic mesenchymal cells.
They mostly occur in visceral pleura, but rarely in the
retroperitoneum [1,2]. In the retrospective analysis of
three cases of pathologically confirmed retroperitoneal
SFTs in this article, their CT imaging and pathology
were studied for the purpose of further improving the
diagnostic accuracy in retroperitoneal SFTs.Case presentations
Case one
Case one was a 22-year-old female who suffered from
intermittent abdominal pain in central right position for
6 years, with paroxysmal pain radiating to the right
waist, which relieved after resting. Upon physical exam-
ination, a palpable tough-quality mass in central right
abdomen was seen, with no tenderness and rebound ten-
derness. Enhanced abdominal CT showed a lobulated* Correspondence: drwujingtao@126.com
†Equal contributors
1Department of Radiology, Northern Jiangsu People’s Hospital, Yangzhou
University, 98, Nantong West Road, Yangzhou 225001, China
Full list of author information is available at the end of the article
© 2014 Sun et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.soft tissue mass on the right retroperitoneum, 160 mm ×
105 mm × 66 mm in size and with a clear boundary. The
solid part of the tumor in the arterial phase showed a
moderately heterogeneous enhancement, with a CT value
of about 76 HU. A plexiform disordered vascular shadow
was visible, together with extensive unenhanced low-
density cystic areas (Figure 1A). A sustained and het-
erogeneously enhanced solid part of the scanned mass
was observed in both the venous and delayed phase,
with a CT value of about 152 to 181 HU. There was no
enhancement for low-density cystic areas, although
envelope enhancement was seen, with a CT value of
about 27 to 30 HU (Figure 1B). The surrounding struc-
tures shifted under compression. Surgical resection
was performed using a retroperitoneal approach, and a
lobulated mass on the right retroperitoneum was vis-
ible in surgery. It enveloped the right ureter, showing a
clear boundary with the kidney but no significant ad-
hesions. With regards to surgical pathology, the gross
morphology showed an envelope on the tumor surface,
with a texturized gray cut surface and a fish-like pat-
tern in the local area. Two regions within the tumor
were visible under the microscope, with the focus area
composed of spindle cells, which were dense and in a. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Retroperitoneal solitary fibrous tumor in a 22-year-old woman. (A) Solid part of the tumor in arterial phase is in moderate, uneven
enhancement with extensive vessel, and unenhanced low-density cystic areas are visible inside. (B) The solid part of the tumor in the venous
phase is insignificant, with uneven or no enhancement in low-density cystic areas, but envelope enhancement is visible. (C) Tumor cells with
admixed thin and thick, collagen fibers. There is a relative demarcation between the hypercellular and hypocellular areas under the microscope.
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the focus area, with obvious edema (Figure 1C). Immuno-
histochemistry showed CD34, CD99 (+++), SMA, CK,
NSE, Calretinin (−), S-100, and bcl-2 (+).Case two
Case two was a 61-year-old female, who developed a
huge retroperitoneal placeholder as indicated by examin-
ation. The patient had neither chest tightness, shortness
of breath, difficulty in breathing, nor abdominal discom-
fort. Upon physical examination, the abdomen was flat
and soft, with no palpable mass. Plain chest and abdominal
CT scans showed a huge soft tissue mass shadow fused by
multiple nodules of varying sizes on the right retroperito-
neum, approximately 164 mm× 150 mm× 116 mm in size.
Heterogeneous density and extensive low-density cystic
areas were seen, with CT values of 25 to 40 HU, and clear
boundaries with the surrounding organs. There was a shift
in the heart, and the liver and right kidney were under
compression, as well as the aorta and inferior vena cava.
Varicose veins in the abdomen were also observed. The
solid part of the mass in the arterial phase was moderately
and heterogeneously enhanced, with a CT value of about
83 HU, and a plexiform disordered vascular shadow was
visible (Figure 2A). The solid part of the scanned mass in
the venous and delayed phases was more enhanced in a
sustained and heterogeneous manner, with CT values of 99
to 123 HU. No enhancement was observed in low-density
cystic areas although a significant enhancement in the
envelope was visible. Multi-planar reconstruction displayed
the tumor size, location, and relationship with the sur-
rounding tissue more clearly (Figure 2B–D). Due to the
high surgical risks as determined by consultation, a retro-
peritoneal tumor biopsy was performed under CT guidance.
The tumor cells were in fusiform shape in a bundle-like,
spiral arrangement under the microscope, rich in sinusoids,
and interstitial collagen denaturation in the focus area
(Figure 2E). Immunohistochemistry showed CD34 (++),
bcl-2 (++), CD99 (++), F8 (+); CD117 (−), Desmin (−),
S-100 (−), and CK (−). Because of the rich vascularsupply and the potential risks of surgery, the mass was
treated with embolization. After two subsequent CT
examinations, 3 and 6 months later, the tumor was un-
changed with regards to size and appearance.Case three
Case three was a 66-year-old male, who developed a
huge retroperitoneal placeholder in the pelvic cavity, as
revealed by examination. The patient had no back pain
or hematuria, no abdominal distention or abdominal
pain, and no sychnuria, urgency, or dysuria. A plain
pelvic CT scan showed a huge retroperitoneal soft tissue
mass on the right side of the bladder, approximately
78 mm × 63 mm × 58 mm in size, with a heterogeneous
density. Multiple cystic areas of low density were seen,
with CT values of 25 to 40 HU, and with unclear bound-
aries with the neighboring bladder (Figure 3A). The solid
part of the mass was moderately and heterogeneously
enhanced in the arterial phase, with a CT value of about
95 HU, and a thickened disordered vascular shadow was
visible (Figure 3B). The solid part of the scanned mass in
the venous phase was further enhanced in a heteroge-
neous manner, with a CT value of 105 to 136 HU. No
enhancement for low-density cystic areas was seen, while a
significant envelope enhancement was visible (Figure 3C).
The retroperitoneal tumor on the right side of the pelvic
cavity was visible in surgery, with adhesions on the left side
of the bladder and the right side of the pelvic cavity, and
the envelope rich in surface blood vessels. Surgical path-
ology showed hyperplasia with a bundle-like structure and
a storiform arrangement was seen under the microscope.
The tumor cells were rich, dense, and in fusiform shape in
most areas, but sparse in others. Rich blood vessels were
seen in interstitium, with partial interstitial collagen de-
naturation and coagulation necrosis in a small focus area.
Fibrous tissue hyperplasia was seen on the outside of
some tumor tissues, with lymphocytic infiltration in-
side (Figure 3D). Immunohistochemistry showed CD34
(++), CD99 (+), bcl-2 (+), S100 (−), CD117 (−), NSE
(−), Desmin (−), and SMA (−).
Figure 2 Right retroperitoneal solitary fibrous tumor in a 61-year-old woman. (A) Transverse arterial phase shows a huge soft tissue mass
fused by multiple nodules of varying sizes, and the solid part is in moderate, uneven enhancement. (B and C) Multi-planar reconstruction in
venous phase shows that the solid part of the tumor is in more significant, sustained, uneven enhancement, no enhancement in low-density
cystic areas, but envelope enhancement is visible. (D) The solid part has sustained enhancement in the delayed phase. (E) Tumor cells were
fusiform with a bundle-like, spiral arrangement under the microscope, rich sinusoids and interstitial collagen denaturation were observed in
the focus areas.
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The onset age of SFTs is 19 to 85 years old, and the age
of peak incidence is 40 to 60 years old. SFTs are more
common in women. In our study, there were two female
patients. Visceral pleura is the most common site of SFT
occurrence, but there are more than 1/3 of SFTs occur-
ring outside of the thoracic cavity, including in the head
and neck, spinal cord, abdominal and pelvic cavity, re-
spiratory tract and surrounding soft tissue, among others
[3-9]. The main clinical manifestations of thoracic SFTs
are chest pain, cough, breathing difficulty, low blood
sugar, and pulmonary hypertrophic osteoarthropathy.Figure 3 Retroperitoneal solitary fibrous tumor in a 62-year-old man.
side of the bladder in uneven density. (B) The solid part in arterial phase is
areas of low density are visible inside. (C) The solid part in venous phase is
in low-density cystic areas, but envelope enhancement is visible. (D) The tu
with branching vascular channels, collagenous bundles, and coagulation necrThe specific clinical manifestations of extrapleural SFTs
depend on the location and size of the tumor. Retroperi-
toneal SFTs are rare [10,11], and mainly presents as a
painless mass, which can grow very large. The clinical
symptoms are mostly caused by the space-occupying
tumor mass. In this group, one case visited the doctor
due to abdominal pain caused by the huge tumor, and
the remaining two cases were asymptomatic and acciden-
tally discovered during physical examination. The gross
specimens of typical SFTs were lobulated, tough-quality
tumors with clear boundary or with (pseudo) envelope.
Pedicles attached to normal tissues were visible in some(A) CT scan shows huge retroperitoneal soft tissue mass on the right
in moderate, uneven enhancement, with tumor vessel, and cystic
in more significant, sustained, uneven enhancement, no enhancement
mor was composed of rich, dense, fusiform cells under the microscope,
osis in focus areas.
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be seen in a small number of tumors. The section was
rigid and gray, often with a texturized, spiral-shaped ap-
pearance. Myxoid degeneration, hemorrhage, and necrosis
were visible, and some may have had calcification. The
basic histological changes were as follows: the sizes of
tumor cells were relatively consistent, with a small amount
of cytoplasm, in short- to long-spindle shape, and homo-
geneously distributed nuclear chromatin. The typical cell
arrangement was patternless. The dense and loose cell
zones coexisted and were separated by fibrous intersti-
tium. Rich blood vessels were seen in the tumor, with
dilated thick-walled blood vessels in perivascular sclerosis,
and a typical hemangiopericytoma-like tumor could be
found. Immunohistochemistry showed that 79 to 100% of
the tumor cells had positive expression for CD34, which
was a highly specific marker of SFTs [12]. Furthermore,
positive CD99 and bcl-2 expressions also had a certain
diagnostic value, while S-100 expression was negative [13].
CT can be used to identify the focus area and clarify
the origin. It is also important in revealing the character-
istics of tumor growth to some extent, as well as for effi-
cacy and prognosis evaluation. The retroperitoneal SFT
was mostly lobulated and large, in round or oval shape,
and grew slowly in an expansive way. The surrounding
tissues mostly shifted under compression. In the three
cases discussed herein, the maximum diameter was above
160 mm, and a significant extrusion occurred to the sur-
rounding organs. The organs were deformed under com-
pression. Most tumors have intact envelopes, which is an
important feature of retroperitoneal SFTs [14]. In all three
cases, the enhanced envelope shadow was visible. In plain
CT scan, the tumors had a homogeneous or heterogeneous
density, which was equal to or slightly higher compared
with the muscle density. Two common intratumoral soft
tissue components in different densities were closely re-
lated to the content of collagen fibers. The cell-sparse zone
had an increased density due to the large number of colla-
gen fibers, while the dense zone had reduced density due
to the relatively small number of collagen fibers. When
cystic degeneration, necrosis, and myxoid degeneration
occurred, the tumor density became more heterogeneous
[1,3,7,9]. Combining with literature [1,6,8], the SFT en-
hancement patterns are closely related to the densities of
tumor blood vessels and tumor cells and the distribution
of dense collagen. There were basically three patterns; first,
mild enhancement or no enhancement, with a degree of
enhancement in each scan phase not exceeding 50% of the
plain CT value. The enhancement can be heterogeneous,
mostly without necrosis. Second, moderate enhancement,
with an enhancement degree of 50 to 100%, and the
enhancement can be homogeneous or heterogeneous, with
necrosis rarely seen. Third, significant enhancement, with an
enhancement degree greater than 100%. This enhancementpattern is similar to that of hemangiopericytoma, with het-
erogeneous enhancement and relatively common necrosis.
Dynamic enhancement is mostly sustained enhancement or
progressively delayed enhancement with a long duration.
The blood vessels visible within the tumor are visible in the
arterial phase. In the three cases, the scans showed heteroge-
neous density, with no calcification. The solid part of the
tumor was significantly and heterogeneously enhanced, with
an enhancement degree exceeding 100%, and the enhance-
ment was sustained. The enhancement features of retroperi-
toneal SFTs in our group were in agreement with the third
type. They were similar to the enhancement features of ab-
dominal and retroperitoneal SFTs reported in the literature
[7,9,14]. Such an enhancement pattern is related to a variety
of patterns of histological arrangement. The cell dense zone
and the hemangiopericytoma-like area have a significant en-
hancement, while the cell sparse zone and the collagen fiber
hyaline degeneration zone have relatively weak enhance-
ment. Areas with different enhancement degrees are mixed.
Myxoid degeneration and the loose arrangement of the cells
can cause the expansion of extracellular space. The con-
trast agent in the extracellular space has progressive accu-
mulation but slower expurgation, which leads to sustained
enhancement. A plexiform, disordered, thickened, and
increased vascular shadow was seen in the arterial phase,
which reflects the presence of a hemangiopericytoma-like
tumor pathologically.
MRI can accurately show the histological features of
retroperitoneal SFTs, which has great value for tumor
diagnosis. However, the three cases discussed herein did
not undergo this procedure. According to the literature
[1,4,5,7,9,10], T1WI generally had equal or slightly lower
signals compared with muscle, while T2WI signals were
in large variations and could be represented by a variety
of signals. Equal or slightly high signals, and internally
scattered flake-like or nodular low signals were the typ-
ical MRI manifestations for most SFTs. T2WI high
signals reflected the myxoid degeneration area in the
tumor, slightly high signals reflected the cell dense zone
in the tumor, and low signals reflected the dense colla-
gen fibers. Due to inconsistencies in SFT vessels, intra-
tumor cells, and dense collagen in terms of density, the
enhanced tumors can show a variety of enhancement
patterns, from mild to significant enhancement. Most
abdominal SFTs show moderate and above enhance-
ment. Irregular necrosis areas are visible in huge tumors.
Gastrointestinal stromal tumors, neurogenic tumors,
and soft tissue sarcoma, among others, need to be dis-
tinguished from retroperitoneal SFTs.
Conclusions
In short, retroperitoneal SFTs are rare, with no typical
clinical manifestations, and therefore it is often difficult
to make a correct preoperative diagnosis. CT imaging of
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http://www.wjso.com/content/12/1/324retroperitoneal SFTs usually shows the following charac-
teristics: large tumors with clear boundaries, intratu-
moral solid components in two different densities, cystic
degeneration, necrosis, and myxoid degeneration, sig-
nificant enhancement and a visibly enhanced envelope.
These features can be used as the criteria for differen-
tial diagnosis for tumors originating from the retroperito-
neum. The confirmed diagnosis still depends on histological
and immunohistochemical examinations.
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